If I understand the question correctly.... There are investments being made in viral vector capacity here, as well, so that could be an opportunity, as well, down the road to produce them here.
However, in terms of viral vector vaccines, those may also be available for other parts of the world. As you were suggesting and Joanne was saying, the RNA vaccines are present here. We've had a role for the viral vector vaccines for sure. What that role may be in the future, it may be more available, more amenable, or more desirable for other parts of the globe. Certainly, we do have viral vector capability here in some cases, and if there were a need or a desire to—